{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:59Z","timestamp":1758815039513},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T00:00:00Z","timestamp":1108944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T00:00:00Z","timestamp":1108944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1038\/sj.bmt.1704872","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T10:07:36Z","timestamp":1108980456000},"page":"683-689","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency"],"prefix":"10.1038","volume":"35","author":[{"given":"M A","family":"Slatter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Abinun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Cant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A R","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,21]]},"reference":[{"key":"BF1704872_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","volume":"361","author":"C Antoine","year":"2003","unstructured":"Antoine C, Muller S, Cant A et al, for the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399. Lancet 2003; 361: 553\u2013560.","journal-title":"Lancet"},{"key":"BF1704872_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","volume":"97","author":"AH Filipovich","year":"2001","unstructured":"Filipovich AH, Stone JV, Tomany SC et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott\u2013Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598\u20131603.","journal-title":"Blood"},{"key":"BF1704872_CR3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","volume":"103","author":"AR Gennery","year":"2004","unstructured":"Gennery AR, Khawaja K, Veys P et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993\u20132002. Blood 2004; 103: 1152\u20131157.","journal-title":"Blood"},{"key":"BF1704872_CR4","first-page":"741","volume":"17","author":"TG Gross","year":"1996","unstructured":"Gross TG, Filipovich AH, Conley ME et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17: 741\u2013744.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704872_CR5","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","volume":"100","author":"RA Seger","year":"2002","unstructured":"Seger RA, Gungor T, Belohradsky BH et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985\u20132000. Blood 2002; 100: 4344\u20134350.","journal-title":"Blood"},{"key":"BF1704872_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJM200106073442304","volume":"344","author":"O Baud","year":"2001","unstructured":"Baud O, Goulet O, Canioni D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758\u20131762.","journal-title":"N Engl J Med"},{"key":"BF1704872_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM199902183400703","volume":"340","author":"RH Buckley","year":"1999","unstructured":"Buckley RH, Schiff SE, Schiff RI et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508\u2013516.","journal-title":"N Engl J Med"},{"key":"BF1704872_CR8","first-page":"543","volume":"17","author":"RM Kline","year":"1996","unstructured":"Kline RM, Stiehm ER, Cowan MJ . Bone marrow \u2018boosts\u2019 following T cell-depleted haploidentical bone marrow transplantation. Bone Marrow Transplant 1996; 17: 543\u2013548.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704872_CR9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood.V96.4.1239","volume":"96","author":"P Amrolia","year":"2000","unstructured":"Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000; 96: 1239\u20131246.","journal-title":"Blood"},{"key":"BF1704872_CR10","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221\u20133227.","journal-title":"Blood"},{"key":"BF1704872_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00043426-199302000-00002","volume":"15","author":"RR Quinones","year":"1993","unstructured":"Quinones RR . Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol 1993; 15: 3\u201317.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BF1704872_CR12","first-page":"626","volume":"23","author":"CS Rosenfeld","year":"1995","unstructured":"Rosenfeld CS, Rybka WB, Weinbaum D et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995; 23: 626\u2013629.","journal-title":"Exp Hematol"},{"key":"BF1704872_CR13","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1128\/JVI.72.6.5006-5015.1998","volume":"72","author":"HP Steffens","year":"1998","unstructured":"Steffens HP, Podlech J, Kurz S et al. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 1998; 72: 5006\u20135015.","journal-title":"J Virol"},{"key":"BF1704872_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1046\/j.1365-2141.1999.01443.x","volume":"105","author":"RE Johnston","year":"1999","unstructured":"Johnston RE, Geretti AM, Prentice HG et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999; 105: 1041\u20131043.","journal-title":"Br J Haematol"},{"key":"BF1704872_CR15","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V94.7.2236.419k04_2236_2246","volume":"94","author":"A Green","year":"1999","unstructured":"Green A, Clarke E, Hunt L et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999; 94: 2236\u20132246.","journal-title":"Blood"},{"key":"BF1704872_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.bmt.1701290","volume":"22","author":"M Remberger","year":"1998","unstructured":"Remberger M, Ringden O, Ljungman P et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73\u201378.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704872_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood-2004-03-0960","volume":"105","author":"K Rao","year":"2004","unstructured":"Rao K, Amrolia PJ, Jones A et al. Improved survival after unrelated donor bone marrow transplant in children with primary immunodeficiency using a reduced intensity conditioning regime. Blood 2004; 105: 879\u2013885.","journal-title":"Blood"},{"key":"BF1704872_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000046513","volume":"104","author":"CK Min","year":"2000","unstructured":"Min CK, Kim DW, Lee JW et al. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Acta Haematol 2000; 104: 185\u2013192.","journal-title":"Acta Haematol"},{"key":"BF1704872_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","volume":"29","author":"SN Wolff","year":"2002","unstructured":"Wolff SN . Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545\u2013552.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704872_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"JH Antin","year":"2001","unstructured":"Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001; 7: 473\u2013485.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704872_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood-2002-01-0211","volume":"100","author":"K Yamaguchi","year":"2002","unstructured":"Yamaguchi K, Ariga T, Yamada M et al. Mixed chimera status of 12 patients with Wiskott\u2013Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood 2002; 100: 1208\u20131214.","journal-title":"Blood"},{"key":"BF1704872_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-3476(96)70248-2","volume":"129","author":"H Ozsahin","year":"1996","unstructured":"Ozsahin H, Le Deist F, Benkerrou M et al. Bone marrow transplantation in 26 patients with Wiskott\u2013Aldrich syndrome from a single center. J Pediatr 1996; 129: 238\u2013244.","journal-title":"J Pediatr"},{"key":"BF1704872_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bmt.1704434","volume":"33","author":"P Lang","year":"2004","unstructured":"Lang P, Klingebiel T, Schumm M et al. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott\u2013Aldrich syndrome 10 years ago. Bone Marrow Transplant 2004; 33: 879\u2013880.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704872","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:32:18Z","timestamp":1648081938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,21]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,4,1]]}},"alternative-id":["BF1704872"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704872","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,21]]},"assertion":[{"value":"30 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}